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ABSTRACT
Menopause and the associated declines in ovarian
function are major health issues for women. Despite
the widespread health impact of this process,
the molecular mechanisms underlying the aging-
specific decline in ovarian function are almost
completely unknown. To provide the first gene–
protein analysis of the ovarian transition to meno-
pause, we have established and contrasted RNA
gene expression profiles and protein localization
and content patterns in healthy young and peri-
menopausal mouse ovaries. We report a clear dis-
tinction in specific mRNA and protein levels that are
noted prior to molecular evidence of steroidogenic
failure. In this model, ovarian reproductive aging
displays similarities with chronic inflammation and
increased sensitivity to environmental cues. Overall,
our results indicate the presence of mouse climac-
teric genes that are likely to be major players in
aging-dependent changes in ovarian function.
INTRODUCTION
The sharp decline in ovarian supply of germ cells and dra-
matic change in endocrine function is a midlife female
aging process leading to menopause. During the transitional
or perimenopausal phase, the ovary undergoes accelerated
depletion of oocytes coinciding with decreases in fertility
and diminished steroidogenic capacity (1). It is not known
whether normally occurring ovarian aging is entirely regu-
lated by the loss of germ cells and accompanying steroid-
producing follicular cells, or whether the ovary shares
generalized or tissue-speciﬁc aging pathways observed in
other models and tissues (2,3). If this is the case, then identi-
fying the major aging pathways that affect the ovary may
have important implications for women during the meno-
pausal transition that go beyond the loss of estrogen. Drawing
upon aging research in other tissues and model systems (2,3),
ovarian changes at the level of RNA and protein are likely to
mark the transition to menopause and thereby provide insight
into ovary-dependent health and disease.
To provide the ﬁrst global assessment of aging pathways
in the ovary, we aimed to deﬁne general and tissue-speciﬁc
proﬁles of ovarian gene expression levels and protein content
of ovaries from young (6-week-old) and perimenopausal
(8-month-old) C57BL/6 mice. To maximize our ability to
identify aging-dependent pathways, we screened for changes
in gene expression using a global mouse array and combined
the results with an aging-speciﬁc mouse DNA array (4) and
northern blot assays. This analysis was followed by a cross-
examination for changes in protein content and cellular
protein location of differentially expressed genes by immuno-
chemistry. We identiﬁed genes for which both mRNA and
protein accumulate differentially with reproductive age. Our
ﬁndings argue for the presence of mouse ’climacteric
genes’ that are likely to be major players in the changes in
ovarian function with reproductive aging.
MATERIALS AND METHODS
Animals
The animal protocol used in this study was approved by the
National Cancer Institute Animal Safety and Use Committee.
Young animals were virgin reproductively mature and
cycling 6-week-old female C57BL/6 mice. Climacteric (peri-
menopaual) animals were cycling and hormonally responsive
8-month-old C57BL/6 female mice that were signiﬁcantly
less active than the young animals and had been retired
recently from breeding (5). Young and old mice were each
divided into four groups (A, B, C and D) of 6–12 mice
each (Figure 1). Identical experiments were done simultane-
ously in young and old mice. Anestrus was induced by group-
housing mice for 1 week and conﬁrmed by conventional
vulvovaginal appearance. Estrus was initiated and follicle
development was synchronized with a standard treatment of
5 IU equine chorionic gonadotropin followed by 5 IU of
human chorionic gonadotropin (hCG) for 48 h. Four hours
after hCG and before anticipated ovulation, ovaries were
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phosphate-buffered saline (PBS) and pooled. Ovaries from
groups A, B and C were divided and processed for RNA
isolation or protein analysis and those from group D were
processed for immunohistochemistry.
Oligonucleotide LabChip array
We analyzed total RNA isolated from two pools (young and
old) of 12 ovaries from 12 young and old animals, respec-
tively (Group A, Figure 1). Two identical microarrays (Agi-
lent 2100) were used to compare both pools. RNA was
quantiﬁed and the quality of these RNA samples was exam-
ined using RNA 6000 Nano LabChip  Kit on Agilent
2100 Bioanalyzer Nanochip to ensure the integrity of RNA
samples before use. The RNA samples from each experi-
mental group (young or old) were pooled, thus creating
RNA mixes (ovary-young and ovary-old) that were further
used for gene expression analyses. Cyanine 3- or 5-labeled
CTP (10.0 mM) were purchased from Perkin–Elmer/NEN
Life Science. Fluorescently labeled cRNA targets were gener-
ated from 500 ng of total RNA for each reaction using the
Agilent Fluorescent Linear Ampliﬁcation Kit following the
protocol described in the user’s manual. Each RNA mix
was labeled with both cyanine 3 and cyanine 5 to allow the
performing of dye reversal experiments to minimize the
impact of dye bias.
Hybridization was performed using the Agilent’s in situ
Hybridization Plus kit with 1 mg labeled cRNA as recom-
mended by the supplier. The arrays were scanned using the
Agilent dual-laser DNA microarray scanner and the data
were then extracted from images by Agilent’s Feature Extrac-
tion software 6.1. Genes were deﬁned as signiﬁcant when sig-
niﬁcantly under- or over-expressed in young versus old
ovary, as determined by the Signiﬁcance Analysis of
Microarrays (SAM) software (http://www-stat.stanford.edu/
~tibs/SAM/) which contains a sliding scale for false dis-
covery rate (FDR) of signiﬁcantly upregulated genes (6).
The output criteria from two microarrays selected for SAM
included 2-fold or greater levels (P < 0.05) in the old ovary
tissues as compared with young ovary tissues, and a signiﬁ-
cance threshold expected to produce a median FDR of
<10 genes. A 3-fold difference in hybridization levels (deter-
mined by Agilent) in young compared with old was selected
as a threshold for signiﬁcance and the corresponding genes
were further studied.
Mouse aging-specific oligonucleotide array
We analyzed three sets of 12 pooled young and 12 pooled
old ovaries independently (Groups A, B and C, Figure 1).
The RNA pool used for the Agilent microarray experiment
(RNA pool A) was included to verify consistencies between
array experiments. RNA was used to prepare cDNA as
described earlier (4).
32P-labeled cDNA (25ng) was hybrid-
ized to an aging-speciﬁc mouse oligo DNA array containing
probes for 160 genes as described previously (4). Each
hybridization reaction was performed in duplicate. Twelve
identical DNA membranes were used for the comparative
hybridizations. The array contains 65 genes that are not pre-
sented in the LabChip array from Agilent. Spot reading was
performed using a Phosphorimager (Molecular Dynamics)
(a)
(b)
(c)
Figure 1. Flow diagram of experimental design. (a) Forty-two young
(6 weeks) and 42 old (8 months) mice were divided into four groups (A, B, C
and D) of 6 or12 mice. Animals in all four groups were identically treated for
synchronized ovarian follicle development. For each animal the ovaries were
divided such that one was included in pools for RNA analysis and the other in
pools for proteomic analysis. Both ovaries from group D mice were used for
immunohistochemistry (IHC). (b) RNA was extracted from group A ovaries
(n ¼ 12) and specific differences in RNA levels in young and old pools were
first tested by the OligoChip oligonucleotide array (6000 genes) in duplicate
reactions. RNA pools A, B and C were also tested in three independent
experiments using six identical aging-specific oligonucleotide arrays (160
genes) in duplicate reactions. RNA’s with significant differences in
oligonucleotide hybidization reactions between young and old samples were
then tested by northern analysis (48 genes) in groups A, B and C. (c) The
genes with confirmed differences at the level of RNA were evaluated for
differences in protein levels. Western blots for the proteins of these genes
were performed on protein pools A, B and C in three independent
experiments using duplicate blot reactions. These proteins were also probed
in situ by immunofluorescence using triplicate frozen tissue sections from the
ovaries in group D.
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calculation of signal density using ImageQuant (Amersham
Biosciences) software. Data were imported into Excel
(Microsoft) and analyzed as described previously (4).
Virtual northern analysis
Virtual northern analysis was performed to conﬁrm level
changes in RNA for genes with consistent 3-fold or greater
differences in expression between young and old ovaries as
described previously (4). For a single hybridization 2 mgo f
total RNA was used. As above, 12 pooled young and
12 pooled old ovaries were used for total RNA isolation
(Qiagen) and repeated in three replicate sets of experiments.
This included testing one RNA pool (pool A) that had been
used in the arrays which were also analyzed for consistency.
Hybridization reading and data analyses were performed as
described in Materials and Methods.
Protein analysis by western blot
Whole ovaries pooled from three pools of 12 young and old
ovaries were homogenized at 4 C in buffer containing 20 mM
HEPES, 50 mM NaCl, 1 mM EDTA, 5 mM DTT and pro-
tease inhibitors (Protease inhibitor cocktail; Sigma). SDS
(1%) was added to the homogenates and after centrifugation
(50 000 g for 20 min at 4 C) the resulting supernatants were
collected for protein analysis. Protein lysates (100 mg) were
analyzed for presence of speciﬁc proteins by western blotting.
Exposed ﬁlms were scanned using a UMAX 1100 Powerlook
scanner and Adobe Photoshop. Protein concentration was
determined using BSA as a standard (Pierce kit). Duplicate
conﬁrmatory western blots were performed.
Immunofluorescence
Surgically dissected ovaries from six young and six old mice
were snap frozen and stored at  80 C in Tissue Freezing
Medium (Triangle Biomedical Sciences, Inc.). Sections
(5 mm) were ﬁxed in acetone and 10% buffered formalin
and stained with hemotoxylin and eosin. For immunoﬂuores-
cence, sections were ﬁxed in 4% paraformaldehyde, washed
with PBS, 0.05% Tween, 0.05% saponin and brieﬂy treated
with 0.5% Triton X-100 prior incubation with protein-speciﬁc
antibodies. Sections were incubated with secondary antibod-
ies conjugated to FITC or Alexa488, Alexa596 (Molecular
Probes), Cy3 or Cy5 (Sigma) and visualized using a Zeiss
Axioskop 2 microscope, Zeiss Axiocam and Photoshop. As
negative control sections were incubated with the secondary
antibodies alone (data not shown). For autoﬂuorescence stud-
ies, fresh cryosections were directly visualized using a Zeiss
Axioskop 2 microscope and Zeiss Axiocam. All antibody
experiments were performed in duplicate with young and
old ovary sections from different animals.
RESULTS
To provide a global screen of changes in gene expression
as ovarian function declines, we contrasted morphological
structure, speciﬁc RNA and protein levels between isolated
ovaries of estrus-synchronized young and old mice. The ﬂow
diagram of the experimental design is presented in Figure 1.
Young 6-week-old mice were cycling and reproductive
competent compared with perimenopausal 8-month-old mice
that were still cycling and hormonally responsive but were
reproductively compromised by age-dependent infertility (5).
Morphological changes with ovarian
reproductive aging
All ovaries consistently contained mature antral follicles
(Figure 2a and b). Morphological analysis of hematoxylin
and eosin stained cryosections revealed a gross reduction in
the total number mature follicles and an increase in interven-
ing stromal tissue in retired breeder ovaries (Figure 2b). Fluo-
rescent microscopy of ovarian cryosections revealed the
presence of a signiﬁcant amount of autoﬂuorescent inclusions
(4) in the aged ovaries (Figure 2d). A signiﬁcantly smaller
amount of autoﬂuorescent inclusions were observed in
young ovaries (Figure 2c).
Comparative genomic analysis of healthy
young and perimenopausal ovaries
Initially, we compared RNA levels from both ages in two sets
of hybridization analyses with a gene array containing 6000
mouse genes. Following duplicate sets of independent hybrid-
ization experiments, we conﬁrmed decreased levels of 42
transcripts with aging and increased levels of 68 transcripts.
(a) (b)
(c) (d)
Figure 2. Microscopic analysis of young and aged ovaries. (a) Hematoxylin
and eosin stained sections of young ovaries and (b) old ovaries. Black arrows
mark the follicles. Autofluorescence of young (c) and old ovarian cryosections
(d) visualized with excitation filter in the the green (560–580 nm) spectral
regions. Cellular DNA was fluorescently stained with Hoechst 33342 (blue)
and visualized with the excitation filter in the blue (350–461 nm) spectral
regions. Pictures were taken at magnification ·600.
Nucleic Acids Research, 2006, Vol. 34, No. 11 3281We performed an additional gene expression analysis using a
mouse oligonucleotide array developed for aging-related dif-
ferentially expressed genes (Figure 3a and b). The array con-
tains probes for 160 genes identiﬁed previously to change
level in the progression of cardiac aging (4). Several genes
on this array are not presented in the large LabChip array.
With the aging-speciﬁc array, 26 transcripts were conﬁrmed
to decrease with aging and 31 increased. Of these 57 tran-
scripts, 32 were conﬁrmed by both arrays. To further validate
the arrays data we analyzed mRNA levels in young and older
ovaries by virtual northern blotting for 52 selected available
gene probes corresponding to those transcripts conﬁrmed pre-
viously to be expressed differentially with aging. Figure 4a
displays an example of the northern slot blot assays per-
formed. Five clones were conﬁrmed to be present at a signiﬁ-
cantly lower level in the older relative to young ovaries
including leptin receptor, TGFb, transcription factor Yin
Yang 1 (YY1), jagged 1 and desmin (Figure 4b and
Table 1). Increased levels in older ovaries were found for
eight genes including NFkB, retinoic receptor, Jak1, heme-
oxygenase-1, ubiquitin and telomerase (Figure 4c and
Table 1). No change was observed for cytochrome B and
its mRNA level was used as a control for equal RNA loading
in the experiments (Figure 4d).
Proteomics analyses of differentially expressed genes in
young and perimenopausal ovaries to confirm changes
at protein level and tissue distribution
We veriﬁed the protein level for the differentially expressed
genes by applying western blot with total ovarian lysates
and immunoﬂuorescence on frozen tissue sections with
protein-speciﬁc antibodies. The results of the western blot
analyses are displayed in Figure 5. With aging, total protein
content of estrogen sulfotransferase, transcription factors
YY1, SP1 and GATA3, the cell signaling factors GDP
dissociation inhibitor-1 as well as Janus kinase 1, and the
post-translational protein modifying ubiquitin decreased
(Figure 5a). Stress-induced factor heme-oxygenase-1, the
cell signaling factors GDP dissociation inhibitor-2 and
purinergic receptor P2X2 protein levels increased with aging
(Figure 5c). The remaining proteins corresponding to genes
with changes in mRNA expression level demonstrated no sig-
niﬁcant change with aging or were undetectable (examples
shown in Figure 5c).
Immunoﬂuorescent histochemical analyses conﬁrmed
aging-related decreases in protein levels of transcription
factors YY1, SP1 and GATA3, the signal transduction
kinase Jak1, ubiquitin, proliferation marker Ki67 and desmin
all with similar patterns of cellular and tissue localization.
Staining with antibodies against the stress response enzyme
heme-oxygenase-1, transcription factors NFkB, retinoic
receptor a, A20, the nucleotide cell signaling molecules
GDP dissociation inhibitor-2, the purinergic receptor P2X2
and telomerase reverse transcriptase (TERT) revealed
increases in protein content. Examples of the 26 proteins
screened by immunohistochemistry demonstrating conﬁrma-
tory increased or decreased levels are shown in Figure 6.
Also observed were decreased histochemical levels of estro-
gen sulfotransferase, which previously demonstrated
increased RNA levels. Differential staining of young oocytes
was notable for estrogen sulfotransferase EST and ubiquitin-
speciﬁc antibodies. EST in old ovaries was prominently local-
ized to the surface epithelium. We noted a prominent
increased localization of NFkB (Figure 6b) and HO-1 in
the follicular layer and the ovarian surface epithelium of
old ovaries. This pattern was shared by zinc ﬁnger protein
A20 (Figure 6b).
The remaining proteins examined with aging-related
changes at RNA level demonstrated no perceptible level
change by western blot and immunohistochemistry. As an
example in Figure 6c, the retinoic acid receptor (RAR)
alpha staining with marked localization in the antral follicle
thecal layer in both young and old ovaries is shown.
The results from our genomic and protein comparative
studies are summarized in Table 1. Additional mRNAs
were found to change level with aging, but their proteins
remained essentially at the same level for both ages.
DISCUSSION
Ovarian aging resembles the cellular aging of other mamma-
lian and invertebrate systems to some extent. The signiﬁcant
accumulation of autoﬂuorescent inclusions observed in aged
ovaries is consistent with the accumulation of lipofuscin in
aged cardiac muscle (4). Increased lipofuscin likely typiﬁes
a cumulative response to lipid peroxidation and oxidative
stress (7) and was observed prominently in the stroma and
perivascular tissue of the ovarian medulla and hilum of
older ovaries. Our results demonstrate signiﬁcant follicular
depletion and decreased generalized proliferation with
aging. Further, intervening stroma was increased in all
regions of older ovaries. Our results indicate signiﬁcantly
reduced level of desmin mainly in the perifollicular stroma
in old ovaries. Lower desmin content would ultimately result
in reduced cellular contractility (8,9) leading to reduced
(a) (b)
Figure 3. DNA array to confirm differential gene expression in young and old
ovaries. Identical DNA array membranes containing probes for 440 aging-
related mouse genes were probed with individual
33P-labeled cDNA libraries
prepared from (a) young and (b) aged ovaries. Lower panels of (a)
and (b) show an enlargement of the framed membrane portions in the upper
panels. Matrix overlay maps the position of the nucleotides for each gene.
Positions 62, Leptin; 79, CD36 antigen; 117, unknown EST are examples of
decreased levels with aging. Positions 58, peroxisome proliferators activated
receptor-a; 105, transcription factor NFkB are examples of increased levels
with aging.
3282 Nucleic Acids Research, 2006, Vol. 34, No. 11follicle contraction and changes in the atretic process (1).
The ovarian architectural aging response may be character-
ized by stromal remodeling concurrent with loss of cortical
follicular units and the accumulation of autoﬂuorescent
inclusions.
Based on substantial clinical data from women with age-
related ovarian failure, it is believed that changes in steroid
and growth factor-related mechanisms may be causative or
consequential factors in ovarian aging (10). The present
hypotheses of human ovarian aging propose signiﬁcant
changes in steroid content and activity. Surprisingly, our
data did not reveal changes in steroid-producing proteins
and growth factors. We observed upregulation of mRNA
levels of EST, aromatase, progesterone receptor and TGF-b
without coincident changes at the level of protein. We
observed downregulation of leptin at the level of mRNA
but not at the level of protein. Our ﬁndings may indicate
that appreciable aging changes in the ovary are operative
prior to evidence of steroidogenic failure. Alternatively,
aging could change the stability of these proteins, involving
the heat-shock protein–ubiquitin–proteasome pathway
through the enhanced level of Hsp70 (11). Furthermore,
a growing body of evidence supports a role for variation of
the rates of mRNA decay as an important process in aging
and that the response to stress is in part mediated by stab-
ilizing or destabilizing cofactors such as heat-shock factors.
For example, differential stability of aromatase mRNA tran-
scripts under stress conditions has been demonstrated in
ovarian cell culture lines (12).
We noted that ovaries in older animals had considerable
upregulation of stress response factors Hsp70, Hsc70 and
Hsp32 (HO-1), all of which are members of inﬂammatory
and oxidative stress response aging pathways. A change in
Hsp70, Hsc70 and Hsp32 is a common feature of aging in
skeletal muscle, cardiac muscle and brain (4,13,14). Hsp70
functions as a critical chaperone for steroid receptors and
forms receptor–steroid complexes with Hsp90 and p23 that
are capable of binding to hormone response elements on
DNA to regulate transcription (15). In human ovarian granu-
losa cells, heat shock induces a robust Hsp70 response (16).
Further, Hsp70 is capable of halting ovarian follicular apop-
tosis by blocking the activity of caspase proteases or inhibit-
ing chaperone-mediated protein import to the mitochondria
(17). Our observation of an age-dependent increase of
heme-oxygenase-1 (HO-1, Hsp32) suggests that upregulation
of protective oxidative stress mechanisms is a feature of early
ovarian aging. HO-1 is inducible by heme compounds, heavy
metals, sulfhydryl reagents and hydrogen peroxide. It func-
tions to remove lipophilic pro-oxidant heme molecules from
(a)
(b)
(c)
(d)
Figure 4. Autoradiograms of representative virtual northern blots that
confirm changes in mRNA levels in young and old ovaries. (a) One of the
three confirmatory virtual northern blots with a complete set of 48 genes
probed in young and old samples. The matrix overlay maps the position of
each reaction. Three independent northern blot experiments produced
consistent results (SD ¼ 3%). (b) Examples of genes that are downregulated
in perimenopausal ovaries compared with young ovaries: leptin receptor
at position 37 in (a); desmin at position 10 in (a); TGF-b at position 24.
(c) Examples of genes that are upregulated in perimenopausal ovaries: heme-
oxygenase-1, position 45 in (a); nuclear factor kB, position 46; retinoic
receptor-a, position 19; janus kinase 1, position 32; telomerase, position 44.
(d) An example of a gene with no change in level with aging, cytochrome B,
position 3 in (a) and the control. Hybridization paper was blotted with
oligonucleotides (1 mg) that are specific for different genes and then
hybridized with
32P-labeled ssDNA from young (y) and old (o) mouse
ovaries. Genes to which the probes correspond, are shown to the left of the
autoradiograms. The level of cytochrome B mRNA did not change
significantly with aging and was used as an internal control. Hybridization
in the absence of oligonucleotides was used as a negative control (control).
Nucleic Acids Research, 2006, Vol. 34, No. 11 3283the system, generating antioxidant biliverdin molecules and
mediating an important cellular defense against oxygen free-
radical damage. Our ﬁnding of increased expression of the
pro-inﬂammatory transcription factor NFkB in conjunction
with increased HO-1 indicates that mechanistic changes are
occurring in inﬂammatory pathways (18) during mammalian
ovarian aging. We also observed aging-related increases in
A20, a zinc ﬁnger protein that is induced by NFkB and itself
downregulates NFkB-dependent chronic inﬂammation via
ubiquitin signaling pathways (19). In addition, we observed
changes in expression of RARa and PPARa, both of which
are potential modulators of inﬂammation involving the action
of NFkB and ubiquitin-proteasome degradation (20,21). The
upregulated expression of heat-shock proteins and associated
inﬂammatory stress response factors could signiﬁcantly con-
tribute to changes in ovarian sensitivity to environment.
Aging might either induce repression or fail to trigger path-
ways that lead to activation of speciﬁc transcription promot-
ers. The levels of transcription factors could also be
modulated by the synergistic action of different signaling
pathways. Transcription factors YY1 and Sp1 decline and
NFkB mRNAs increase with ovarian aging. YY1 is a zinc
ﬁnger transcription factor that inﬂuences expression of a
wide variety of genes including HSP70 and HO-1. YY1 inter-
acts with transcription regulators such as Sp1 and p300 (22).
YY1 and NFkB compete for binding sites on a cytokine
response unit (23). Together transcription factors YYI,
NFkB and Sp1 have been implicated in aging mechanisms
involving responses to reactive oxygen species and inﬂamma-
tory cytokines (24). Our ﬁndings of downregulation of YY1
and Sp1 and upregulation of NFkB suggest that transcrip-
tional regulatory responses to oxidative stress may be impor-
tant features of the aging ovarian system and that these
processes may be targets for modulation of aging-dependent
decline of ovarian function.
We observed alterations in protein members of the Notch
signaling pathway, which is generally associated with
changes in cellular activation and proliferation. Downregula-
tion of Jagged1 and Notch3 mRNA levels is associated with
ovarian aging. The Notch pathway has been implicated in
mediating folliculogenesis in the mammalian ovary (25). In
Drosophila, activation of Notch and Jak/STAT signaling
pathways are critical in regulating polarity in early oogenesis
via communication between somatic follicular cells and
germ-line cells such that disruption of this pathway leads
to defective oocyte development (26). An anti-aging
regenerative role for Notch signaling has been suggested in
muscle and other tissues (27). If tissue regeneration is an
important response to the cumulative aging in the ovary
due to repeated cycles of folliculogenesis and regression,
Notch pathways may be important mediators of aging-related
stromal remodeling.
Table 1. Genes with age-dependent changes in mRNA and protein levels in mouse ovaries
Accession Gene RNA Protein
Level Method Level Method
Steroids and growth factors
TC188770 OB Leptin D 2,3 NC 4
M13177 Transforming growth factor B D 2,3 NC 4
NM_023135 Estrogen sulfotransferase U 1 D 4,5
D000659 Aromatase U 1 NC 4,5
NM_008829 Progesterone receptor U 1 NC 4
Transcription factors
NM_009537 Yin Yang 1 D 2,3 D 4,5*
AF022363 SP1 D 3 D 4,5*
M57999 Nuclear factor kb U 2,3 U 5**
X57528 Retinoic acid receptor a U 2,3 U 5**
BC062915 GATA-3 U 1,3 D 5
NM_011144 Peroxisome proliferatory-activated receptor a U 1,2,3 NC 4,5
Cell signaling
BC037598 GDP dissociation inhibitor 1 D 1,3 D 4,5*
AA152708 Jagged1 D 1,2,3 NC 4,5
NM_008716 Notch 3 D 1,3 NC 4,5
UO7951 GDP dissociation inhibitor 2 U 1 U 4**
NM_153400 Purinergic receptor P2X2 U 1 U 4,5**
BC031297 Janus kinase 1 U 2,3 D 4,5
Stress-induced
NM_010442 Heme oxygenase 1 U 2,3 U 4,5**
U73744 Heat shock cognate 70 U 2,3 U 4**
M35021 Heat shock protein 70 U 3 NC 4
Other
L22550 Desmin D 1,2,3 D 5*
X82786 Ki-67 cell proliferation antigen D 1 D 5*
NM_016960 Small inducible cytokine subfamily A20 U 1 U 5**
AF051911 Telomerase reverse transcriptase U 2,3 U 5**
BC100341 Ubiquitin U 2,3 D 4,5
Genes with age-dependent differential expression at the level of mRNA were identified by (1) mouse LabChip array; (2) virtual northern analysis; and (3) DNA
aging-specific gene array. Genes included above were confirmed to change with aging >3-fold in duplicate assays. These genes were then screened for differential
protein content by western blotting (4) and (or) localization by immunofluorescence (5). From left to right, the table columns are the GenBank accession number,
encoded gene, upregulation (U) or downregulation (D) with aging, methodology used to quantify and compare mRNA levels and protein content. Single asterisk
marks genes downregulated both at the level of RNA and protein and double asterisk marks genes upregulated both at the level of RNA and protein.
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sensitivity and signaling pathways could explain the func-
tional decline in endocrine function and fertility. Our results
indicate heightened expression of purinergic receptor P2X2 at
(a)
(b)
(c)
Figure 6. Immunofluorescence microscopy. Ovarian cryosections were
incubated with protein-specific antibodies and fluorescently tagged secondary
antibodies (green or red). Nuclear DNA was stained with Hoechst 33342
(blue). (a) Proteins that decrease level with aging; (b) proteins with increased
level in young ovaries; and (c) no change in protein level. The identity of the
protein-specific antibodies is indicated at the left. The immunofluorescent
staining of young (Y) and old (O) is indicated at the top of the panels. Images
at (a) and (c) are taken at ·600 magnification. They are presented as an
overlay of the protein staining layer on Hoechst-stained DNA image. The
images in (b) are taken at ·200 magnification without Hoechst staining.
(a)
(b)
(c)
Figure 5. Western blots of total protein lysates from young and old mouse
ovaries. (a) Proteins with reduced content in old (o) ovaries compared with
young ovaries (y); (b) proteins with higher level in young ovaries; and (c)n o
change in protein content. Proteins were visualized with protein-specific
antibodies as indicated at the left of the panels. The size (kDa) of the protein
marker is indicated at the right of the panels. All lanes received 100 mg
of total ovarian lysate. The immunological reactions are visualized by
HSP-coupled secondary antibodies.
Nucleic Acids Research, 2006, Vol. 34, No. 11 3285both mRNA and protein levels in older ovaries. Elevated
local ATP released during biological processes of cell
death, noxious stimuli and inﬂammation stimulates purinergic
P2X receptors. P2X receptors appear to be regulated in
response to cellular stresses, which may be a direct effect
of stress-induced changes in ATP levels (28). Our ﬁnding
of increased P2X2 with aging suggests an altered ovarian
responsiveness to ATP and this increase may be ovarian
speciﬁc as decreases in P2X receptors have been observed
with aging in other tissues. The P2X2 receptor is a glycopro-
tein ligand-gated channel with functional capacity and current
conduction correlated with its level of glycosylation. Interest-
ingly, we have observed alterations in protein glycosylation
with ovarian aging (data not shown). However, whether
increased P2X2 receptor protein level via glycosylation-
related proteolytical stability is a feature of the aging
response in the ovary remains to be explored. Nevertheless,
increased receptor level may signiﬁcantly contribute to
changes in ovarian mechanisms of adaptation and sensitivity
to environment.
Alterations in nucleotide cell signaling mediators, guanine
(GDP) dissociation inhibitors 1 and 2 (GDI-1 and GDI-2),
can be demonstrated as well. GDI-1 levels decrease with
ovarian aging while GDI-2 increases. GDIs bind to and
inhibit GDP release from signaling proteins in Rho and Rac
families thereby mediating pathways involved in prolifera-
tion, differentiation, apoptosis, cytoskeletal organization and
cellular trafﬁcking (29). Modiﬁcation of GDI through nitra-
tion is prominent ﬁnding in aging skeletal muscle (30) sug-
gesting a role for GDI metabolism in aging. Rho-GDI
functions as a transactivator for nuclear steroid receptors
and upregulates transcriptional activity of estrogen, androgen
and glucocorticoid receptors transcriptional activity (31).
This mechanism could provide a link between changes in
GDI signaling, nucleotide sensitivity and steroid responsive-
ness in aging ovarian tissue.
In summary, our results demonstrate that early mouse
aging and waning reproductive capacity alters ovarian
mRNA and protein levels. Although the primary regulation
of reproductive aging in rodents and humans may differ, in
our climacteric model we demonstrate clear architectural evi-
dence of ovarian aging including follicular depletion and stro-
mal remodeling. Such changes are typical also for the human
ovarian response to aging supporting the possible validity of
this model for human perimenopausal ovarian aging. How
exactly the mouse model differs from human ovarian aging,
is yet to be established. While the depletion of germ cells
is accepted as a major determinant of ovarian aging, our
gene expression proﬁling suggests that reproducible changes
in gene expression and protein processing coincide with
aging-dependent follicular loss and functional decline. Inter-
estingly, the gene expression patterns observed in this climac-
teric model are evident before coexistent molecular evidence
for steroidogenic failure. The speciﬁc pattern of gene expres-
sion in ovarian aging differs from muscle, brain and cardiac
aging indicating a tissue-speciﬁc aging response. However,
the general functional pathways implicated during early loss
of ovarian capacity resemble aging pathways conserved in
model organisms. In particular, our data suggest that activa-
tion of pro-inﬂammatory and anti-proliferative pathways is
a prominent feature of ovarian aging. Increased sensitivity
to the environment via nucleotide signaling pathways may
be another important adaptation to aging in the ovary. Such
pathways could profoundly inﬂuence the early pathologic
changes in the ovaries observed in premature and aging-
related ovarian failure. How exactly the subset of mRNAs
is selected for expression changes with ovarian aging and
whether these changes modulate aging-dependent germ cell
loss remains to be determined.
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